Phase I/IIa, Single-Arm, Open Study of Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
Phase of Trial: Phase I/II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Apatinib (Primary) ; Irinotecan (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 14 Jun 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 14 Jun 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.
- 14 Jun 2017 Status changed from not yet recruiting to recruiting.